Oncology Outlook 2017
- CLAYTON SMITH, MD PhD Radium-223 for Metastatic Prostate Cancer ( Download)
- Optimizing Therapy with Radium-223 for Prostate Cancer ( Download)
- Bone-Targeted Therapy for Prostate Cancer: Radium-223 ( Download)
- Should Radium 223 Be Given Earlier to Metastatic Prostate Cancer Patients ( Download)
- What Combination Drugs with Radium 223 Are Best for Treating Prostate Cancer ( Download)
- Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Download)
- Bone-migrated prostate cancer and Radium-223 therapy ( Download)
- Radium-223 in mCRPC ( Download)
- Dr. Saad on Results of Radium-223 Trial in Prostate Cancer ( Download)
- Challenges of dealing with prostate cancer patients on Radium-223 ( Download)
- Dr. Miklos on the Safety Profile of KTE-X19 in MCL ( Download)
- Dr. Miklos on Alternative Options to KTE-X19 in MCL, While Awaiting FDA Decision ( Download)
- Dr. Callander on Treatment Considerations in Multiple Myeloma ( Download)
- Dr. Miklos on the Results of the ZUMA-2 Trial in MCL ( Download)
- Dr. Miklos on Development Process for KTE-X19 in MCL ( Download)
